Single Use Bioreactors Market

Single Use Bioreactors Market (4th Edition): Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Bioreactor (Stirred Tank Bioreactor, Wave-Induced Bioreactor, Other Bioreactors), Scale of Operation (Preclinical / Clinical, Commercial), Type of Cell Culture (Mammalian, Microbial, Others), Type of Biologics Synthesized (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapies, Cell Therapies, Others), End Users and Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America)

  • Lowest Price Guaranteed

  • Pages
    356

  • Last Updated
    December 2025

  • View Count
    26546

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Single-use Bioreactors
3.2.1. Historical Evolution
3.2.2. Single-use versus Traditional Bioreactors

3.3. Types of Single-use Bioreactors
3.3.1. Based on Cell Culture
3.3.2. Based on Agitation Mechanism

3.4. Advantages of Single-use Bioreactors
3.5. Key Applications Areas
3.6. Prevalent Regulatory Standards
3.7. Challenges Associated with Single-use Bioreactors
3.8. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Single-use Bioreactors: Overall Market Landscape
4.2.1. Analysis by Type of Bioreactor
4.2.2. Analysis by Scale of Operation
4.2.3. Analysis by Working Volume
4.2.4. Analysis by Stirrer Speed
4.2.5. Analysis by Weight of Bioreactor
4.2.6. Analysis by Advanced Display / Control Features
4.2.7. Analysis by Mode of Operation
4.2.8. Analysis by Type of Culture
4.2.9. Analysis by Type of Cell Culture
4.2.10. Analysis by Type of Biologics Synthesized
4.2.11. Analysis by End-users

4.3. List of Single-use Bioreactor Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters (Region)
4.3.4. Analysis by Location of Headquarters (Country)

4.4. Leading Manufacturers: Analysis by Number of Products

5. KEY INSIGHTS
5.1. Chapter Overview
5.2. Analysis by Company Size and Location of Headquarters
5.3. Analysis by Company Size and Type of Single-use Bioreactor
5.4. Analysis by Type of Single-use Bioreactor and Mode of Operation
5.5. Analysis by Type of Single-use Bioreactor and Type of Biologics Synthesized
5.6. Analysis by Scale of Operation, Type of Cell Culture and Type of Biologics Synthesized
5.7. Analysis by Location of Headquarters

6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions / Key Parameters

6.4. Single-use Bioreactor Manufacturers: Company Competitiveness Analysis
6.4.1. Small Companies
6.4.2. Mid-sized Companies
6.4.3. Large Companies

7. SINGLE-USE BIOREACTOR MANUFACTURERS IN NORTH AMERICA: COMPANY PROFILES
7.1. Chapter Overview
7.2. Leading Players based in North America
7.2.1. Celartia
7.2.1.1. Company Overview
7.2.1.2. Product Portfolio
7.2.1.3. Recent Developments and Future Outlook

7.2.2. Cell Culture Company
7.2.2.1. Company Overview
7.2.2.2. Product Portfolio
7.2.2.3. Recent Developments and Future Outlook

7.2.3. Cytiva
7.2.3.1. Company Overview
7.2.3.2. Product Portfolio
7.2.3.3. Recent Developments and Future Outlook

7.2.4. Merck Millipore
7.2.4.1. Company Overview
7.2.4.2. Financial Information
7.2.4.3. Product Portfolio
7.2.4.4. Recent Developments and Future Outlook

7.2.5. Pall Corporation
7.2.5.1. Company Overview
7.2.5.2. Product Portfolio
7.2.5.3. Recent Developments and Future Outlook

7.2.6. PBS Biotech
7.2.6.1. Company Overview
7.2.6.2. Product Portfolio
7.2.6.3. Recent Developments and Future Outlook

7.2.7. Synthecon
7.2.7.1. Company Overview
7.2.7.2. Product Portfolio
7.2.7.3. Recent Developments and Future Outlook

7.2.8. Thermo Fisher Scientific
7.2.8.1. Company Overview
7.2.8.2. Financial Information
7.2.8.3. Product Portfolio
7.2.8.4. Recent Developments and Future Outlook

8. SINGLE-USE BIORECTOR MANUFACTURERS IN EUROPE, ASIA-PACIFIC AND REST OF THE WORLD: COMPANY PROFILES
8.1. Chapter Overview
8.2. Leading Players based in Europe, Asia-Pacific and Rest of the World
8.2.1. Applikon Biotechnology
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Recent Developments and Future Outlook

8.2.2. Cellexus
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Recent Developments and Future Outlook

8.2.3. CerCell
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Recent Developments and Future Outlook

8.2.4. Eppendorf
8.2.4.1. Company Overview
8.2.4.2. Financial Information
8.2.4.3. Product Portfolio
8.2.4.4. Recent Developments and Future Outlook

8.2.5. PerfuseCell
8.2.5.1. Company Overview
8.2.5.2. Product Portfolio
8.2.5.3. Recent Developments and Future Outlook

8.2.6. ProlifeCell
8.2.6.1. Company Overview
8.2.6.2. Product Portfolio
8.2.6.3. Recent Developments and Future Outlook

8.2.7. Sartorius Stedim Biotech
8.2.7.1. Company Overview
8.2.7.2. Financial Information
8.2.7.3. Product Portfolio
8.2.7.4. Recent Developments and Future Outlook

8.2.8. Solaris Biotech
8.2.8.1. Company Overview
8.2.8.2. Product Portfolio
8.2.8.3. Recent Developments and Future Outlook

8.3. Leading Players based in Asia-Pacific and Rest of the World
8.3.1. Biolinx Labsystems
8.3.1.1. Company Overview
8.3.1.2. Product Portfolio
8.3.1.3. Recent Developments and Future Outlook

8.3.2. CESCO Bioengineering
8.3.2.1. Company Overview
8.3.2.2. Product Portfolio
8.3.2.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models

9.3. Single-use Bioreactors: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Analysis by Year of Partnership and Focus Area
9.3.6. Analysis by Type of Partner
9.3.7. Analysis by Type of Biologics Synthesized
9.3.8. Analysis by Type of Bioreactor Involved
9.3.9. Analysis by Location of Facility (Country) and Expanded Bioreactor Capacity
9.3.10. Most Active Players: Analysis by Number of Partnerships

9.3.11. Analysis by Geography
9.3.11.1. Local and International Agreements
9.3.11.2. Intracontinental and Intercontinental Agreements

10. PRODUCT COMPETITIVENESS ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Assumptions / Key Parameters

10.4. Single-use Bioreactors: Product Competitiveness Analysis
10.4.1. Stirred Tank Single-use Bioreactors
10.4.1.1. Products Offered by Players based In North America
10.4.1.2. Products Offered by Players based In Europe
10.4.1.3. Products Offered by Players based In Asia-Pacific and Rest of the World

10.4.2. Fixed-Bed Single-use Bioreactors
10.4.3. Wave-Induced / Rocking Single-use Bioreactors

10.4.4. Other Types of Single-use Bioreactors
10.4.4.1. Products Offered by Players based In North America
10.4.4.2. Products Offered by Players based In Europe
10.4.4.3. Products Offered by Players based In Asia-Pacific and Rest of the World

11. BRAND POSITIONING ANALYSIS
11.1. Chapter Overview
11.2. Methodology
11.3. Key Parameters
11.4. Brand Positioning Matrix
11.5. Brand Positioning Matrix: Pall Corporation
11.6. Brand Positioning Matrix: Biolinx Labsystems
11.7. Brand Positioning Matrix: Eppendorf
11.8. Brand Positioning Matrix: Solaris Biotech
11.9. Brand Positioning Matrix: Sartorius Stedim Biotech
11.10. Brand Positioning Matrix: Applikon Biotechnology
11.11. Brand Positioning Matrix: Cercell

12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology

12.3. Single-use Bioreactors: Patent Analysis
12.3.1. Analysis by Publication Year
12.3.2. Analysis by Application Year
12.3.3. Analysis by Type of Patents and Publication Year
12.3.4. Analysis by Patent Jurisdiction
12.3.5. Analysis by CPC Symbols
12.3.6. Analysis by Type of Applicant
12.3.7. Leading Industry Players: Analysis by Number of Patents
12.3.8. Leading Patent Assignees: Analysis by Number of Patents

12.4. Single-use Bioreactors: Patent Benchmarking Analysis
12.4.1. Analysis by Patent Characteristics

12.5. Single-use Bioreactors: Patent Valuation
12.6. Leading Patents by Number of Citations

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Key Assumptions and Methodology

13.3. Global Single-use Upstream Bioprocessing Technology Market, till 2035
13.3.1. Global Single-use Upstream Bioprocessing Technology Market: Distribution by Scale of Operation, till 2035
13.3.2. Global Single-use Upstream Bioprocessing Technology Market: Distribution by Type of Equipment, till 2035
13.3.3. Global Single-use Upstream Bioprocessing Technology Market: Distribution by Geographical Region, till 2035

13.4. Global Single-use Bioreactors Market, till 2035
13.4.1. Global Single-use Bioreactors Market: Distribution by Type of Bioreactor, till 2035
13.4.2. Global Single-use Bioreactors Market: Distribution by Scale of Operation, till 2035
13.4.3. Global Single-use Bioreactors Market: Distribution by Type of Cell Culture, till 2035
13.4.4. Global Single-use Bioreactors Market: Distribution by Type of Biologics Synthesized, till 2035
13.4.5. Global Single-use Bioreactors Market: Distribution by End-users, till 2035
13.4.6. Global Single-use Bioreactors Market: Distribution by Geographical Region, till 2035

14. CASE STUDY: KEY TECHNOLOGICAL INNOVATIONS IN THE SINGLE-USE BIOREACTORS INDUSTRY
14.1. Chapter Overview
14.2. Innovations in Bioreactor Display / Control Features
14.2.1. Built-in System Control Sensors
14.2.2. Advanced Alarm Systems
14.2.3. Electronic-Log Records and Touch Screens
14.2.4. Real-Time Tracking and Remote Monitoring

14.3. Innovation in Mixing Technologies
14.4. Automation in Single-use bioreactors
14.5. Concluding Remarks

15. SWOT ANALYSIS
15.1. Chapter Overview
15.2. Single-use Bioreactors: SWOT Analysis
15.3. Strengths
15.4. Weaknesses
15.5. Opportunities
15.6. Threats
15.7. Comparison of SWOT Factors

16. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS
16.1. Chapter Overview
16.2. Bioprocess Control Software: Overall Market Landscape
16.2.1. Analysis by Scale of Operation
16.2.2. Analysis by Key Features
16.2.3. Analysis by Compatibility with System
16.2.4. Analysis by Type of Process Controlled

16.3. Bioprocess Control Software Developers: Overall Market Landscape
16.3.1. Analysis by Year of Establishment
16.3.2. Analysis by Company Size
16.3.3. Analysis by Location of Headquarters

16.4. Upstream Controllers: Overall Market Landscape
16.4.1. Analysis by Scale of Operation
16.4.2. Analysis by Key Features
16.4.3. Analysis by Compatibility with Bioreactor System
16.4.4. Analysis by Type of Bioprocess
16.4.5. Analysis by Type of Process Controlled

16.5. Upstream Controller Developers: Overall Market Landscape
16.5.1. Analysis by Year of Establishment
16.5.2. Analysis by Company Size
16.5.3. Analysis by Location of Headquarters

16.6. Downstream Controller Systems: Overall Market Landscape
16.6.1. Analysis by Scale of Operation
16.6.2. Analysis by Key Features
16.6.3. Analysis by Type of System
16.6.4. Analysis by Type of Bioprocess
16.6.5. Analysis by Application Area

16.7. Downstream Controller System Developers: Overall Market Landscape
16.7.1. Analysis by Year of Establishment
16.7.2. Analysis by Company Size
16.7.3. Analysis by Location of Headquarters

17. CONCLUSION

18. EXECUTIVE INSIGHTS
18.1. Chapter Overview
18.2. Membio
18.2.1. Company Snapshot
18.2.2. Interview Transcript: Founder and Chief Executive Officer

18.3. Distek
18.3.1. Company Snapshot
18.3.2. Interview Transcript: Chief Executive Officer, Senior Technical Product Manager

18.4. Refine Technology
18.4.1. Company Snapshot
18.4.2. Interview Transcript: Quality and Products Manager

18.5. CerCell
18.5.1. Company Snapshot
18.5.2. Interview Transcript: Chief Strategy Officer of R&D, Marketing and Technical Support

18.6. CelVivo
18.6.1. Company Snapshot
18.6.2. Interview Transcript: Global Director of Sales Support

19. APPENDIX I: TABULATED DATA

20. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

21. APPENDIX III: LIST OF BUSINESSES OFFERING BIOPROCESS

List of Figures

Figure 2.1 Executive Summary: Current Market Landscape of Single-use Bioreactors 
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Patent Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Historical Events related to the Development of Single-use Bioreactors
Figure 3.2 Conventional Stainless-steel Bioreactors and Single-use Bioreactors: Energy Consumption (Mega Joules)
Figure 3.3 Conventional Stainless-steel Bioreactors and Single-use Bioreactors: Water Consumption (Kilo Liters)
Figure 3.4 Single-use Bioreactors: Type of Cell Culture Handled
Figure 3.5 Advantages of Single-use Bioreactors
Figure 3.6 Applications of Single-use Bioreactors
Figure 4.1 Single-use Bioreactors: Distribution by Type of Bioreactor
Figure 4.2 Single-use Bioreactors: Distribution by Scale of Operation
Figure 4.3 Single-use Bioreactors: Distribution by Working Volume (Liters)
Figure 4.4 Single-use Bioreactors: Distribution by Stirrer speed (RPM)
Figure 4.5 Single-use Bioreactors: Distribution by Weight of Bioreactor (Kg)
Figure 4.6 Single-use Bioreactors: Distribution by Advanced Display / Control Features
Figure 4.7 Single-use Bioreactors: Distribution by Mode of Operation 
Figure 4.8 Single-use Bioreactors: Distribution by Type of Culture
Figure 4.9 Single-use Bioreactors: Distribution by Type of Cell Culture
Figure 4.10 Single-use Bioreactors: Distribution by Type of Biologics Synthesized
Figure 4.11 Single-use Bioreactors: Distribution by End-users
Figure 4.12 Single-use Bioreactor Manufacturers: Distribution by Year of Establishment
Figure 4.13 Single-use Bioreactor Manufacturers: Distribution by Company Size
Figure 4.14 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Region)
Figure 4.15 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Country)
Figure 4.16 Leading Manufacturers: Distribution by Number of Products
Figure 5.1 Distribution by Company Size of Manufacturer and Type of Single-use Bioreactor
Figure 5.2 Distribution by Type of Single-use Bioreactor and Mode of Operation
Figure 5.3 Heat Map Representation: Distribution by Type of Single-use Bioreactor and Type of Biologics Synthesized
Figure 5.4 Hybrid Chart: Distribution by Scale of Operation, Type of Cell Culture and Type of Biologics Synthesized
Figure 5.5 Distribution by Company Size and Location of Headquarters
Figure 5.6 World Map Representation: Distribution by Location of Headquarters
Figure 6.1 Company Competitiveness Analysis: Small Companies
Figure 6.2 Company Competitiveness Analysis: Mid-sized Companies
Figure 6.3 Company Competitiveness Analysis: Large Companies
Figure 7.1 Danaher (a parent company of Cytiva): Annual Revenues, 2018 - 2022 (USD Billion)
Figure 7.2 Merck Millipore: Annual Revenues, 2017-2022 (EUR Billion)
Figure 7.3 Danaher (a parent company of Pall Corporation): Annual Revenues, 2018 - 2022 (USD Billion)
Figure 7.4 Thermo Fisher Scientific: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Figure 8.1 Eppendorf: Annual Revenues, FY 2018-FY 2022 (EUR Million)
Figure 8.2 Sartorius Stedim Biotech: Annual Revenues, 2018-Q1 2023 (EUR Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-Wise Trend
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 9.5 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.7 Partnerships and Collaborations: Distribution by Type of Biologics Synthesized
Figure 9.8 Partnerships and Collaborations: Distribution by Type of Bioreactor Involved
Figure 9.9 Partnerships and Collaborations: Distribution by Location of Facility (Country) and Expanded Bioreactor Capacity
Figure 9.10 Most Active Players: Distribution by Number of Partnerships
Figure 9.11 Partnerships and Collaborations: Local and International Agreements
Figure 9.12 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 10.1 Product Competitiveness Analysis: Stirred Tank Single-use Bioreactors Offered by Players in North America
Figure 10.2 Product Competitiveness Analysis: Stirred Tank Single-use Bioreactors Offered by Players in Europe
Figure 10.3 Product Competitiveness Analysis: Stirred Tank Single-use Bioreactors Offered by Players in Asia-Pacific and Rest of the World
Figure 10.4 Product Competitiveness Analysis: Fixed-Bed Single-use Bioreactors
Figure 10.5 Product Competitiveness Analysis: Wave-Induced / Rocking Single-use Bioreactors
Figure 10.6 Product Competitiveness Analysis: Other Types of Single-use Bioreactors Offered by Players in North America
Figure 10.7 Product Competitiveness Analysis: Other Types of Single-use Bioreactors Offered by Players in Europe
Figure 10.8 Product Competitiveness Analysis: Other Types of Single-use Bioreactors Offered by Players in Asia-Pacific and Rest of the World
Figure 11.1 Brand Positioning Analysis: Competitive Advantage
Figure 11.2 Brand Positioning Analysis: Reasons to Believe
Figure 11.3 Brand Positioning Matrix: Pall Corporation
Figure 11.4 Brand Positioning Matrix: Biolinx Labsystems
Figure 11.5 Brand Positioning Matrix: Eppendorf
Figure 11.6 Brand Positioning Matrix: Solaris Biotech
Figure 11.7 Brand Positioning Matrix: Sartorius Stedim Biotech
Figure 11.8 Brand Positioning Matrix: Applikon Biotechnology
Figure 11.9 Brand Positioning Matrix: Cercell
Figure 12.1 Patent Analysis: Distribution by Type of Patent
Figure 12.2 Patent Analysis: Cumulative Year-wise Trend by Application Year, Pre-2015–2023
Figure 12.3 Patent Analysis: Cumulative Year-wise Trend by Publication Year, Pre-2015–2023
Figure 12.4 Patent Analysis: Distribution of Type of Patents and Publication Year, Pre-2015-2023
Figure 12.5 Patent Analysis: Distribution by Patent Jurisdiction
Figure 12.6 Patent Analysis: Distribution by CPC Symbols and Sections
Figure 12.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 12.8 Leading Industry Players: Distribution by Number of Patents
Figure 12.9 Leading Patent Assignees: Distribution by Number of Patents
Figure 12.10 Patent Benchmarking Analysis: Distribution of Top Nine Industry Players by CPC Codes
Figure 12.11 Patent Analysis: Distribution by Patent Age
Figure 12.12 Single-use Bioreactors: Patent Valuation
Figure 13.1 Global Single-use Upstream Bioprocessing Technology Market, 2023-2035 (USD Billion)
Figure 13.2 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Scale of Operation, 2023-2035 (USD Billion)
Figure 13.3 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Type of Equipment, 2023-2035 (USD Billion)
Figure 13.4 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Geographical Region, 2023-2035 (USD Billion)
Figure 13.5 Global Single-use Bioreactors Market, 2023-2035 (USD Billion)
Figure 13.6 Global Single-use Bioreactors Market: Distribution by Type of Bioreactor, 2023-2035 (USD Billion)
Figure 13.7 Global Single-use Bioreactors Market: Distribution by Scale of Operation, 2023-2035 (USD Billion)
Figure 13.8 Global Single-use Bioreactors Market: Distribution by Type of Cell Culture, 2023-2035 (USD Billion)
Figure 13.9 Global Single-use Bioreactors Market: Distribution by Type of Biologics Synthesized, 2023-2035 (USD Billion)
Figure 13.10 Global single-use Bioreactors Market: Distribution by Application Area, 2023-2035 (USD Billion)
Figure 13.11 Global single-use Bioreactors Market: Distribution by End-users, 2023-2035 (USD Billion)
Figure 13.12 Global Single-use Bioreactors Market: Distribution by Geographical Region, 2023-2035 (USD Billion)
Figure 14.1 Single-use Bioreactors Market: SWOT Analysis
Figure 14.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 16.1 Bioprocess Control Software: Distribution by Scale of Operation
Figure 16.2 Bioprocess Control Software: Distribution by Key Features
Figure 16.3 Bioprocess Control Software: Distribution by Compatibility with System
Figure 16.4 Bioprocess Control Software: Distribution by Type of Process Controlled
Figure 16.5 Bioprocess Control Software Manufacturers: Distribution by Year of Establishment
Figure 16.6 Bioprocess Control Software Manufacturers: Distribution by Company Size
Figure 16.7 Bioprocess Control Software Manufacturers: Distribution by Location of Headquarters
Figure 16.8 Upstream Controllers: Distribution by Scale of Operation
Figure 16.9 Upstream Controllers: Distribution by Key Features
Figure 16.10 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
Figure 16.11 Upstream Controllers: Distribution by Type of Bioprocess
Figure 16.12 Upstream Controllers: Distribution by Type of Process Controlled
Figure 16.13 Upstream Controller Manufacturers: Distribution by Year of Establishment
Figure 16.14 Upstream Controller Manufacturers: Distribution by Company Size
Figure 16.15 Upstream Controller Manufacturers: Distribution by Location of Headquarters
Figure 16.16 Downstream Controller Systems: Distribution by Scale of Operation
Figure 16.17 Downstream Controller Systems: Distribution by Key Features
Figure 16.18 Downstream Controller Systems: Distribution by Type of System
Figure 16.19 Downstream Controller Systems: Distribution by Type of Bioprocess
Figure 16.20 Downstream Controller Systems: Distribution by Application Area
Figure 16.21 Downstream Controller System Manufacturers: Distribution by Year of Establishment
Figure 16.22 Downstream Controller System Manufacturers: Distribution by Company Size
Figure 16.23 Downstream Controller System Manufacturers: Distribution by Location of Headquarters
Figure 17.1 Concluding Remarks: Current Market Landscape of Single-use Bioreactors
Figure 17.2 Concluding Remarks: Partnerships and Collaborations
Figure 17.3 Concluding Remarks: Patent Analysis
Figure 17.4 Concluding Remarks: Market Forecast and Opportunity Analysis

List of Table

Table 3.1 Comparison between Conventional and Single-use Bioreactors
Table 4.1 Single-use Bioreactors: Information on Manufacturer, Status of Development, Type of Bioreactor and Scale of Operation
Table 4.2 Single-use Bioreactors: Information on Working Volume, Stirrer Speed, Weight and Dimensions of Bioreactor
Table 4.3 Single-use Bioreactors: Information on Advanced Display / Control Features
Table 4.4 Single-use Bioreactors: Information on Mode of Operation
Table 4.5 Single-use Bioreactors: Information on Type of Culture and Type of Cell Culture
Table 4.6 Single-use Bioreactors: Information on Type of Biologics Synthesized
Table 4.7 Single-use Bioreactors: Information on End-users
Table 4.8 Single-use Bioreactors: List of Manufacturers
Table 7.1 Single-use Bioreactors: List of Companies Profiled
Table 7.2 Celartia: Company Snapshot
Table 7.3 Celartia: Product Portfolio
Table 7.4 Cell Culture Company: Company Snapshot
Table 7.5 Cell Culture Company: Product Portfolio
Table 7.6 Cytiva: Company Snapshot
Table 7.7 Cytiva: Product Portfolio
Table 7.8 Merck Millipore: Company Snapshot
Table 7.9 Merck Millipore: Product Portfolio
Table 7.10 Merck Millipore: Recent Developments and Future Outlook
Table 7.11 Pall Corporation: Company Snapshot
Table 7.12 Pall Corporation: Product Portfolio
Table 7.13 Pall Corporation: Recent Developments and Future Outlook
Table 7.14 PBS Biotech: Company Snapshot
Table 7.15 PBS Biotech: Product Portfolio
Table 7.16 PBS Biotech: Recent Developments and Future Outlook
Table 7.17 Synthecon: Company Snapshot
Table 7.18 Synthecon: Product Portfolio
Table 7.19 Thermo Fisher Scientific: Company Snapshot
Table 7.20 Thermo Fisher Scientific: Product Portfolio
Table 7.21 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 8.1 Single-use Bioreactors: List of Companies Profiled
Table 8.2 Applikon Biotechnology: Company Snapshot
Table 8.3 Applikon Biotechnology: Product Portfolio
Table 8.4 Applikon Biotechnology: Recent Developments and Future Outlook
Table 8.5 Cellexus: Company Snapshot
Table 8.6 Cellexus: Product Portfolio
Table 8.7 Cellexus: Recent Developments and Future Outlook
Table 8.8 CerCell: Company Snapshot
Table 8.9 CerCell: Product Portfolio
Table 8.10 CerCell: Recent Developments and Future Outlook
Table 8.11 Eppendorf: Company Snapshot
Table 8.12 Eppendorf: Product Portfolio
Table 8.13 Eppendorf: Recent Developments and Future Outlook
Table 8.14 PerfuseCell: Company Snapshot
Table 8.15 PerfuseCell: Product Portfolio
Table 8.16 PerfuseCell: Recent Developments and Future Outlook
Table 8.17 ProlifeCell: Company Snapshot
Table 8.18 ProlifeCell: Product Portfolio
Table 8.19 ProlifeCell: Recent Developments and Future Outlook
Table 8.20 Sartorius Stedim Biotech: Company Snapshot
Table 8.21 Sartorius Stedim Biotech: Product Portfolio
Table 8.22 Sartorius Stedim Biotech: Recent Developments and Future Outlook
Table 8.23 Solaris Biotech: Company Snapshot
Table 8.24 Solaris Biotech: Product Portfolio
Table 8.25 Solaris Biotech: Recent Developments and Future Outlook
Table 8.26 Biolinx Labsystems: Company Snapshot
Table 8.27 Biolinx Labsystems: Product Portfolio
Table 8.28 CESCO Bioengineering: Company Snapshot
Table 8.29 CESCO Bioengineering: Product Portfolio
Table 9.1 Single-use Bioreactors: List of Partnerships and Collaborations
Table 9.2 Single-use Bioreactors: Information on Location of Partner (Country and Continent)
Table 10.1 Product Competitiveness Analysis: Information on Peer Groups
Table 12.1 Patent Analysis: Top CPC Sections
Table 12.2 Patent Analysis: Top CPC Symbols
Table 12.3 Patent Analysis: Top CPC Codes
Table 12.4 Patent Analysis: Summary of Benchmarking Analysis
Table 12.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 12.6 Patent Analysis: List of Leading Patents (by Number of Citations)
Table 16.1 Bioprocess Control Software: Information on Stage of Bioprocess and Scale of Operation
Table 16.2 Bioprocess Control Software: Information on Key Features, Compatibility with Bioreactor Systems and Processes Controlled
Table 16.3 Bioprocess Control Software Manufacturers: Information of Year of Establishment, Company Size and Location of Headquarters
Table 16.4 Upstream Controllers: Information on Dimensions and Scale of Operation
Table 16.5 Upstream Controllers: Information on Key Features, Type of Bioprocess and Compatibility with Bioreactor Systems, and Processes Controlled
Table 16.6 Upstream Controller Manufacturers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 16.7 Downstream Controller Systems: Information on Dimensions, Type of Controllers and Scale of Operation
Table 16.8 Downstream Controller Systems: Information on Key Features, Type of System, Type of Bioprocess and Application Areas
Table 16.9 Downstream Controller System Manufacturers: Information of Year of Establishment, Company Size and Location of Headquarters
Table 18.1 Membio: Company Snapshot
Table 18.2 Distek: Company Snapshot
Table 18.3 Refine Technology: Company Snapshot
Table 18.4 CerCell: Company Snapshot
Table 18.5 CelVivo: Company Snapshot
Table 19.1 Conventional Stainless-steel Bioreactors and Single-use Bioreactors: Energy Consumption (Mega Joules)
Table 19.2 Conventional Stainless-steel Bioreactors and Single-use Bioreactors: Water Consumption (Kilo Liters)
Table 19.3 Single-use Bioreactors: Distribution by Type of Bioreactor
Table 19.4 Single-use Bioreactors: Distribution by Scale of Operation
Table 19.5 Single-use Bioreactors: Distribution by Working Volume 
Table 19.6 Single-use Bioreactors: Distribution by Stirrer speed
Table 19.7 Single-use Bioreactors: Distribution by Weight of Bioreactor
Table 19.8 Single-use Bioreactors: Distribution by Advanced Display / Control Features
Table 19.9 Single-use Bioreactors: Distribution by Mode of Operation 
Table 19.10 Single-use Bioreactors: Distribution by Type of Culture
Table 19.11 Single-use Bioreactors: Distribution by Type of Cell Culture
Table 19.12 Single-use Bioreactors: Distribution by Type of Biologics Synthesized
Table 19.13 Single-use Bioreactors: Distribution by End-users
Table 19.14 Single-use Bioreactor Manufacturers: Distribution by Year of Establishment
Table 19.15 Single-use Bioreactor Manufacturers: Distribution by Company Size
Table 19.16 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Region)
Table 19.17 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Country)
Table 19.18 Leading Manufacturers: Distribution by Number of Products
Table 19.19 Distribution by Company Size of manufacturer and Type of Single-use Bioreactor
Table 19.20 Distribution by Type of Single-use Bioreactor and Mode of Operation
Table 19.21 Distribution by Company Size and Location of Headquarters
Table 19.22 World Map Representation: Distribution by Location of Headquarters
Table 19.23 Danaher (a parent company of Cytiva): Annual Revenues, 2018 - 2022 (USD Billion)
Table 19.24 Merck Millipore: Annual Revenues, 2017-2022 (EUR Billion)
Table 19.25 Danaher (a parent company of Pall Corporation): Annual Revenues, 2018 - 2022 (USD Billion)
Table 19.26 Thermo Fisher Scientific: Annual Revenues, 2017-2022 (USD Billion)
Table 19.27 Eppendorf: Annual Revenues, 2018-2022 (EUR Million)
Table 19.28 Sartorius Stedim Biotech: Annual Revenues, 2018-Q1 2023 (EUR Million)
Table 19.29 Partnerships and Collaborations: Cumulative Year-Wise Trend
Table 19.30 Partnerships and Collaborations: Distribution by Type of Partnership
Table 19.31 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 19.32 Partnerships and Collaborations: Distribution by Focus Area
Table 19.33 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Table 19.34 Partnerships and Collaborations: Distribution by Type of Partner
Table 19.35 Partnerships and Collaborations: Distribution by Type of Biologics Synthesized
Table 19.36 Partnerships and Collaborations: Distribution by Type of Bioreactor Involved
Table 19.37 Most Active Players: Distribution by Number of Partnerships
Table 19.38 Partnerships and Collaborations: Local and International Agreements
Table 19.39 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 19.40 Patent Analysis: Distribution by Type of Patent
Table 19.41 Patent Analysis: Cumulative Year-wise Trend by Application Year, Pre-2015–2023
Table 19.42 Patent Analysis: Cumulative Year-wise Trend by Publication Year, Pre-2015–2023
Table 19.43 Patent Analysis: Distribution of Type of Patents and Publication Year, Pre-2015-2023
Table 19.44 Patent Analysis: Distribution by Patent Jurisdiction
Table 19.45 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Table 19.46 Leading Industry Players: Distribution by Number of Patents
Table 19.47 Leading Patent Assignees: Distribution by Number of Patents
Table 19.48 Patent Analysis: Distribution by Patent Age
Table 19.49 Single-use Bioreactors: Patent Valuation
Table 19.50 Global Single-use Upstream Bioprocessing Technology Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.51 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.52 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Type of Equipment, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.53 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Geographical Region, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.54 Global Single-use Bioreactor Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.55 Global Single-use Bioreactor Market: Distribution by Type of Bioreactor, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.56 Global Single-use Bioreactor Market: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.57 Global Single-use Bioreactor Market: Distribution by Type of Cell Culture, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.58 Global Single-use Bioreactor Market: Distribution by Type of Biologics Synthesized, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.59 Global single-use Bioreactor Market: Distribution by Application Area, Conservative, Base and Optimistic Scenario,2023-2035 (USD Billion)
Table 19.60 Global single-use Bioreactor Market: Distribution by End-users, Conservative, Base and Optimistic Scenario,2023-2035 (USD Billion)
Table 19.61 Global Single-use Bioreactor Market: Distribution by Geographical Region, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
Table 19.62 Bioprocess Control Software: Distribution by Scale of Operation
Table 19.63 Bioprocess Control Software: Distribution by Key Features
Table 19.64 Bioprocess Control Software: Distribution by Compatibility with Systems
Table 19.65 Bioprocess Control Software: Distribution by Type of Process Controlled
Table 19.66 Bioprocess Control Software Manufacturers: Distribution by Year of Establishment
Table 19.67 Bioprocess Control Software Manufacturers: Distribution by Company Size
Table 19.68 Bioprocess Control Software Manufacturers: Distribution by Location of Headquarters
Table 19.69 Upstream Controllers: Distribution by Scale of Operation
Table 19.70 Upstream Controllers: Distribution by Key Features
Table 19.71 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
Table 19.72 Upstream Controllers: Distribution by Type of Bioprocess
Table 19.73 Upstream Controllers: Distribution by Type of Process Controlled
Table 19.74 Upstream Controller Manufacturers: Distribution by Year of Establishment
Table 19.75 Upstream Controller Manufacturers: Distribution by Company Size
Table 19.76 Upstream Controller Manufacturers: Distribution by Location of Headquarters
Table 19.77 Downstream Controller Systems: Distribution by Scale of Operation
Table 19.78 Downstream Controller Systems: Distribution by Key Features
Table 19.79 Downstream Controller Systems: Distribution by Type of System
Table 19.80 Downstream Controller Systems: Distribution by Type of Bioprocess
Table 19.81 Downstream Controller Systems: Distribution by Application Area
Table 19.82 Downstream Controller System Manufacturers: Distribution by Year of Establishment
Table 19.83 Downstream Controller System Manufacturers: Distribution by Company Size
Table 19.84 Downstream Controller System Manufacturers: Distribution by Location of Headquarters

List of Companies

Please contact our team for the details on the companies covered. 

Source 1: https://www.scienceboard.net/index.aspx?sec=sup&sub=cell&pag=dis&ItemID=803
Source 2: https://www.nature.com/articles/s41587-022-01630-6